FDA Inspection 1334112 — Hill Laboratories

Hill Laboratories — FEI 2510425

The FDA completed an inspection of Hill Laboratories on Sep 3, 2026 in Frazer, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 3, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Frazer, PA (United States)

Citations

IDCFRDescription
23075ISO 13485:2016 Clause 6.2(e)Records of personnel competence not maintained
23088ISO 13485:2016 Clause 7.1Records of risk management activities in product realization not maintained
23219ISO 13485:2016 Clause 8.2.2Complaint handling records not maintained

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.